New England Research & Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,350
| Closed | -$219K | – | 150 |
|
|
2024
Q4 | $219K | Buy |
1,350
+25
| +2% | +$4.06K | 0.11% | 139 |
|
|
2024
Q3 | $216K | Buy |
+1,325
| New | +$216K | 0.1% | 148 |
|
|
2022
Q1 | – | Sell |
-1,200
| Closed | -$209K | – | 167 |
|
|
2021
Q4 | $209K | Sell |
1,200
-50
| -4% | -$8.71K | 0.1% | 175 |
|
|
2021
Q3 | $207K | Hold |
1,250
| – | – | 0.11% | 172 |
|
|
2021
Q2 | $225K | Buy |
+1,250
| New | +$225K | 0.12% | 163 |
|
|
2020
Q1 | – | Sell |
-8,475
| Closed | -$1.3M | – | 142 |
|
|
2019
Q4 | $1.3M | Hold |
8,475
| – | – | 0.87% | 36 |
|
|
2019
Q3 | $1.29M | Sell |
8,475
-300
| -3% | -$45.6K | 0.93% | 30 |
|
|
2019
Q2 | $1.34M | Buy |
8,775
+2,125
| +32% | +$325K | 0.91% | 30 |
|
|
2019
Q1 | $1.07M | Buy |
+6,650
| New | +$1.07M | 0.72% | 48 |
|
|
2018
Q1 | – | Sell |
-5,450
| Closed | -$811K | – | 156 |
|
|
2017
Q4 | $811K | Sell |
5,450
-700
| -11% | -$104K | 0.58% | 69 |
|
|
2017
Q3 | $811K | Sell |
6,150
-150
| -2% | -$19.8K | 0.59% | 65 |
|
|
2017
Q2 | $839K | Sell |
6,300
-50
| -0.8% | -$6.66K | 0.62% | 60 |
|
|
2017
Q1 | $856K | Sell |
6,350
-650
| -9% | -$87.6K | 0.66% | 61 |
|
|
2016
Q4 | $840K | Buy |
+7,000
| New | +$840K | 0.66% | 54 |
|
|
2014
Q3 | – | Sell |
-5,550
| Closed | -$507K | – | 168 |
|
|
2014
Q2 | $507K | Buy |
5,550
+1,350
| +32% | +$123K | 0.45% | 92 |
|
|
2014
Q1 | $370K | Sell |
4,200
-275
| -6% | -$24.2K | 0.34% | 109 |
|
|
2013
Q4 | $415K | Buy |
+4,475
| New | +$415K | 0.4% | 102 |
|